written on 27.03.2014
Tags:
,

GlaxoSmithKline's diabetes contender albiglutide nabs EU approval

TAGS: ,

European officials gave a green light to GlaxoSmithKline's once-weekly diabetes drug Eperzan (albiglutide). The GLP-1 drug is awaiting FDA approval, with a decision expected next month.

Latest Report